CRON vs. APHA, BHC, TLRY, THCX, WEED, GUD, ACB, FIRE, OGI, and EPI
Should you be buying Cronos Group stock or one of its competitors? The main competitors of Cronos Group include Aphria (APHA), Bausch Health Companies (BHC), Tilray Brands (TLRY), Hydropothecary (THCX), Canopy Growth (WEED), Knight Therapeutics (GUD), Aurora Cannabis (ACB), Supreme Cannabis (FIRE), Organigram (OGI), and ESSA Pharma (EPI). These companies are all part of the "drug manufacturers - specialty & generic" industry.
Aphria (TSE:APHA) and Cronos Group (TSE:CRON) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their community ranking, risk, institutional ownership, earnings, dividends, media sentiment, valuation, profitability and analyst recommendations.
Cronos Group has lower revenue, but higher earnings than Aphria. Cronos Group is trading at a lower price-to-earnings ratio than Aphria, indicating that it is currently the more affordable of the two stocks.
Aphria received 312 more outperform votes than Cronos Group when rated by MarketBeat users. Likewise, 68.04% of users gave Aphria an outperform vote while only 50.74% of users gave Cronos Group an outperform vote.
In the previous week, Cronos Group had 1 more articles in the media than Aphria. MarketBeat recorded 1 mentions for Cronos Group and 0 mentions for Aphria. Aphria's average media sentiment score of 0.80 beat Cronos Group's score of 0.00 indicating that Cronos Group is being referred to more favorably in the news media.
15.9% of Cronos Group shares are held by institutional investors. 46.5% of Cronos Group shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Aphria has a net margin of 0.00% compared to Aphria's net margin of -61.31%. Cronos Group's return on equity of 0.00% beat Aphria's return on equity.
Cronos Group has a consensus price target of C$3.18, suggesting a potential downside of 10.17%.
Summary
Aphria beats Cronos Group on 7 of the 13 factors compared between the two stocks.
Get Cronos Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for CRON and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CRON and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Cronos Group Competitors List
Related Companies and Tools
